Departament de Medicina Experimental, Institut de Recerca Biomèdica de Lleida-Universitat de Lleida, Av. Rovira Roure 80, 25198, Lleida, Spain.
Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada.
Neurotherapeutics. 2020 Jan;17(1):269-281. doi: 10.1007/s13311-019-00808-2.
Docosahexaenoic acid (DHA) is an essential fatty acid modulating key nervous system functions, including neuroinflammation, and regulation of pre- and postsynaptic membrane formation. DHA concentration decreases in the lumbar spinal cord (LSC) of amyotrophic lateral sclerosis (ALS) patients and murine preclinical models. Using a dietary supplementation, we increased DHA levels (2% mean increase, p < 0.01) in the LSC of the familial ALS murine model B6SJL-Tg(SOD1*G93A)1Gur/J. This DHA-enriched diet significantly increases male mouse survival by 7% (average 10 days over 130 days of life expectancy), and delays motor dysfunction (based on stride length) and transgene-associated weight loss (p < 0.01). DHA supplementation led to an increased anti-inflammatory fatty acid profile (ca 30%, p < 0.01) and a lower concentration of circulating proinflammatory cytokine TNF-α (p < 0.001 in males). Furthermore, although DHA-treated mice did not exhibit generally decreased protein oxidative markers (glutamic and aminoadipic semialdehydes, carboxyethyllysine, carboxymethyllysine, and malondialdehydelysine), dietary intake of DHA reduced immunoreactivity towards DNA oxidative damage markers (8-oxo-dG) in the LSC. In vitro we demonstrate that DHA and α-tocopherol addition to a model of motor neuron demise (neonatal rat organotypic spinal cord model under chronic excitotoxicity) also preserves motor neuron number, in comparison with untreated spinal cords. Also, beneficial effects on cell viability were evidenced for the motor neuron cell line NSC-34 in front of HO insult (p < 0.001). Globally we show a sex-specific benefit of dietary DHA supplementation in the G93A ALS mouse model, compared with mice fed an isocaloric control or a n-3-depleted diet. These changes were associated with an increased DHA concentration in the LSC and were compatible with in vitro results showing DHA neuroprotective properties. These results suggest the need for further study on the interaction of gender-influenced biological parameters and DHA in ALS pathogenesis.
二十二碳六烯酸 (DHA) 是一种必需脂肪酸,可调节关键的神经系统功能,包括神经炎症和前突触和后突触膜形成的调节。肌萎缩侧索硬化症 (ALS) 患者和鼠临床前模型的腰椎脊髓 (LSC) 中 DHA 浓度降低。通过饮食补充,我们增加了家族性 ALS 鼠模型 B6SJL-Tg(SOD1*G93A)1Gur/J 的 LSC 中的 DHA 水平(平均增加 2%,p<0.01)。这种富含 DHA 的饮食可使雄性小鼠的存活率提高 7%(平均 130 天预期寿命增加 10 天),并延迟运动功能障碍(基于步长)和转基因相关体重减轻(p<0.01)。DHA 补充剂导致抗炎脂肪酸谱增加(约 30%,p<0.01)和循环促炎细胞因子 TNF-α 浓度降低(雄性 p<0.001)。此外,尽管 DHA 处理的小鼠通常没有表现出降低的蛋白质氧化标记物(谷氨酸和氨基己二酸半醛、羧乙基赖氨酸、羧甲基赖氨酸和丙二醛赖氨酸),但 DHA 的饮食摄入减少了 LSC 中 DNA 氧化损伤标记物(8-oxo-dG)的免疫反应性。在体外,我们证明 DHA 和 α-生育酚添加到运动神经元死亡模型(慢性兴奋性毒性下的新生大鼠器官型脊髓模型)中也可以与未经处理的脊髓相比保存运动神经元数量。此外,在面对 HO 损伤时,运动神经元细胞系 NSC-34 的细胞活力也表现出有益作用(p<0.001)。总体而言,与喂食等热量对照或 n-3 耗尽饮食的小鼠相比,我们在 G93A ALS 小鼠模型中显示了饮食 DHA 补充的性别特异性益处。这些变化与 LSC 中 DHA 浓度的增加有关,并且与体外结果一致,表明 DHA 具有神经保护特性。这些结果表明需要进一步研究性别影响的生物学参数与 ALS 发病机制中 DHA 的相互作用。